4595.T Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 09:15):

Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan...

Stats
Šios dienos apimtis	14 800.00
Vidutinė apimtis	75 966.00
Rinkos kapitalizacija	32.00B
EPS	¥0 ( 2024-02-08 )
Kita pelno data	( ¥0 ) 2024-05-09
Last Dividend	¥40.00 ( 2023-06-29 )
Next Dividend	¥0 ( N/A )
P/E	8.48
ATR14	¥2.95 (0.09%)

Mizuho Medy Co.,Ltd. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Mizuho Medy Co.,Ltd. Finansinės ataskaitos

Annual	2023
Pajamos:	¥10.99B
Bruto pelnas:	¥8.03B (73.03 %)
EPS:	¥396.27

FY	2023
Pajamos:	¥10.99B
Bruto pelnas:	¥8.03B (73.03 %)
EPS:	¥396.27

FY	2022
Pajamos:	¥17.58B
Bruto pelnas:	¥14.10B (80.20 %)
EPS:	¥822.94

Financial Reports:

No articles found.

Mizuho Medy Co.,Ltd. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥0 (N/A)	¥190.00 (N/A)	¥0 (N/A)	¥40.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Mizuho Medy Co.,Ltd. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.40 - Stable (12.03%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥9.25	2015-12-28
Last Dividend	¥40.00	2023-06-29
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	12	--
Total Paid Out	¥555.75	--
Avg. Dividend % Per Year	0.00%	--
Score	2.82	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.40
Div. Directional Score	7.34	--

Next Divdend (Est)
(2024-11-29)

¥0 Estimate 3.26 %

Dividend Stability

0.26 Very Poor

Dividend Score

2.82

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8058.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7315.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6564.T	Ex Dividend Junior	2024-03-28	Annually	0.00%
5915.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4578.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
3834.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
3085.T	Ex Dividend Knight	2023-06-29	Semi-Annually	0.00%
1951.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
9507.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
8395.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.343	1.500	3.13	4.70	[0 - 0.5]
returnOnAssetsTTM	0.199	1.200	3.36	4.03	[0 - 0.3]
returnOnEquityTTM	0.262	1.500	8.20	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	7.15	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	6.38	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	3.82	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.0511	-1.500	9.15	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	41.05	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	41.05	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.0618	-1.500	9.75	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.735	1.000	1.089	1.089	[0.2 - 0.8]
operatingProfitMarginTTM	0.469	1.000	2.62	2.62	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.404	1.000	8.87	8.87	[0.2 - 2]
assetTurnoverTTM	0.580	0.800	9.47	7.57	[0.5 - 2]
Total Score				10.28

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	8.47	1.000	9.25	0	[1 - 100]
returnOnEquityTTM	0.262	2.50	8.84	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	41.05	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	2.38	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	41.05	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.135	1.500	-2.43	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0356	1.000	-1.611	0	[0.1 - 0.5]
Total Score				4.40

Mizuho Medy Co.,Ltd.

Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus antigen test kits; rotavirus and adenovirus antigen test kits; norovirus antigen test kits; group a streptococcal antigen test kits; pregnancy test kits; ovulation test kits; and fecal occult blood test kits. It also offers gene analysis instrument; SARS-CoV-2 detection kits; and mycoplasma pneumoniae nucleic acid kits. In addition, the company engages in import and export activities. It also operates in the United States, Belgium, Finland, Netherlands, Taiwan, Thailand, etc. The company was incorporated in 1977 and is headquartered in Tosu, Japan.